Search

Search Constraints

You searched for: Author/Creator García-Rivera, Dagmar

Search Results

1. A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity. Issue 13 (18th March 2022)

2. Cost-effectiveness of introducing a domestic pneumococcal conjugate vaccine (PCV7-TT) into the Cuban national immunization programme. (August 2020)

3. Influence of the Co-Administration of Heptavalent Conjugate Vaccine PCV7-TT on the Immunological Response Elicited by VA-MENGOC-BC® and Heberpenta®-L in Rabbits. (19th May 2017)

4. Multicomponent polysaccharide–protein bioconjugation in the development of antibacterial glycoconjugate vaccine candidates. Issue 9 (8th February 2018)

5. Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children. (January 2023)

6. Prevalence of Pneumococcal Nasopharyngeal Carriage Among Children 2–18 Months of Age: Baseline Study Pre Introduction of Pneumococcal Vaccination in Cuba. Issue 1 (January 2017)

7. Repeat-dose and local tolerance toxicity of SARS-CoV-2 FINLAY-FR-02 vaccine candidate in Sprague Dawley rats. (15th April 2022)

8. Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials. Issue 31 (29th July 2022)

9. Safety and immunogenicity of the Cuban heptavalent pneumococcal conjugate vaccine in healthy infants. Results from a double-blind randomized control trial Phase I. Issue 32 (6th August 2018)

10. Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial. Issue 8 (August 2022)